ArticleRadiation oncology (London, England)2022

Long-term survival of patients with central or > 7 cm T4 N0/1 M0 non-small-cell lung cancer treated with definitive concurrent radiochemotherapy in comparison to trimodality treatment.

Nika Guberina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.